192 related articles for article (PubMed ID: 21266828)
21. Tumour-associated mast cells in classical Hodgkin's lymphoma: correlation with histological subtype, other tumour-infiltrating inflammatory cell subsets and outcome.
Andersen MD; Kamper P; Nielsen PS; Bendix K; Riber-Hansen R; Steiniche T; Hamilton-Dutoit S; Clausen M; d'Amore F
Eur J Haematol; 2016 Mar; 96(3):252-9. PubMed ID: 25963595
[TBL] [Abstract][Full Text] [Related]
22. Prognostic role of tumor-associated macrophages and angiogenesis in classical Hodgkin lymphoma.
Panico L; Ronconi F; Lepore M; Tenneriello V; Cantore N; Dell'Angelo AC; Ferbo U; Ferrara F
Leuk Lymphoma; 2013 Nov; 54(11):2418-25. PubMed ID: 23432688
[TBL] [Abstract][Full Text] [Related]
23. CD68 tumor-associated macrophage marker is not prognostic of clinical outcome in classical Hodgkin lymphoma.
Kayal S; Mathur S; Karak AK; Kumar L; Sharma A; Bakhshi S; Raina V
Leuk Lymphoma; 2014 May; 55(5):1031-7. PubMed ID: 24067108
[TBL] [Abstract][Full Text] [Related]
24. Lack of association of tumor-associated macrophages with clinical outcome in patients with classical Hodgkin's lymphoma.
Azambuja D; Natkunam Y; Biasoli I; Lossos IS; Anderson MW; Morais JC; Spector N
Ann Oncol; 2012 Mar; 23(3):736-742. PubMed ID: 21602260
[TBL] [Abstract][Full Text] [Related]
25. High tumor-infiltrating macrophage density predicts poor prognosis in patients with primary hepatocellular carcinoma after resection.
Ding T; Xu J; Wang F; Shi M; Zhang Y; Li SP; Zheng L
Hum Pathol; 2009 Mar; 40(3):381-9. PubMed ID: 18992916
[TBL] [Abstract][Full Text] [Related]
26. Clinico-pathological significance of immunohistochemically marked tumor-associated macrophage in classic Hodgkin lymphoma.
Abd Allah MYY; Fahmi MW; El-Ashwah S
J Egypt Natl Canc Inst; 2020 Apr; 32(1):18. PubMed ID: 32372254
[TBL] [Abstract][Full Text] [Related]
27. Immunohistochemical expression of angiogenic cytokines in childhood Hodgkin lymphoma.
Citak EC; Oguz A; Karadeniz C; Akyurek N
Pathol Res Pract; 2008; 204(2):89-96. PubMed ID: 18207652
[TBL] [Abstract][Full Text] [Related]
28. High CD20+ background cells predict a favorable outcome in classical Hodgkin lymphoma and antagonize CD68+ macrophages.
Panico L; Tenneriello V; Ronconi F; Lepore M; Cantore N; Dell'Angelo AC; Ferbo L; Ferrara F
Leuk Lymphoma; 2015 Jun; 56(6):1636-42. PubMed ID: 25098425
[TBL] [Abstract][Full Text] [Related]
29. The Lymphoma-Associated Macrophage to Hodgkin-Reed-Sternberg Cell Ratio Is a Poor Prognostic Factor in Classic Hodgkin Lymphoma Patients.
Procházka V; Papajík T; Dýšková T; Dihel M; Brychtová S; Prouzová Z; Kriegová E; Lukášová M; Hanáčková V
Clin Lymphoma Myeloma Leuk; 2019 Oct; 19(10):e573-e580. PubMed ID: 31377208
[TBL] [Abstract][Full Text] [Related]
30. Meta-analysis of the prognostic and clinical value of tumor-associated macrophages in adult classical Hodgkin lymphoma.
Guo B; Cen H; Tan X; Ke Q
BMC Med; 2016 Oct; 14(1):159. PubMed ID: 27745550
[TBL] [Abstract][Full Text] [Related]
31. Prognostic significance of macrophage infiltration in leiomyosarcomas.
Lee CH; Espinosa I; Vrijaldenhoven S; Subramanian S; Montgomery KD; Zhu S; Marinelli RJ; Peterse JL; Poulin N; Nielsen TO; West RB; Gilks CB; van de Rijn M
Clin Cancer Res; 2008 Mar; 14(5):1423-30. PubMed ID: 18316565
[TBL] [Abstract][Full Text] [Related]
32. Evaluation of the diagnostic and prognostic value of PDL1 expression in Hodgkin and B-cell lymphomas.
Menter T; Bodmer-Haecki A; Dirnhofer S; Tzankov A
Hum Pathol; 2016 Aug; 54():17-24. PubMed ID: 27045512
[TBL] [Abstract][Full Text] [Related]
33. CD68 staining correlates with the size of residual mass but not with survival in classical Hodgkin lymphoma.
Agur A; Amir G; Paltiel O; Klein M; Dann EJ; Goldschmidt H; Goldschmidt N
Leuk Lymphoma; 2015 May; 56(5):1315-9. PubMed ID: 25204373
[TBL] [Abstract][Full Text] [Related]
34. Multifunctional immune-modulatory protein HLA-E identified in classical Hodgkin lymphoma: possible implications.
Kren L; Fabian P; Slaby O; Janikova A; Soucek O; Sterba J; Krenova Z; Michalek J; Kral Z
Pathol Res Pract; 2012 Jan; 208(1):45-9. PubMed ID: 22177730
[TBL] [Abstract][Full Text] [Related]
35. Prognostic implication of types of tumor-associated macrophages in Hodgkin lymphoma.
Zaki MA; Wada N; Ikeda J; Shibayama H; Hashimoto K; Yamagami T; Tatsumi Y; Tsukaguchi M; Take H; Tsudo M; Morii E; Aozasa K
Virchows Arch; 2011 Oct; 459(4):361-6. PubMed ID: 21874508
[TBL] [Abstract][Full Text] [Related]
36. Proliferative index and CD15 expression in pediatric classical Hodgkin lymphoma.
Dinand V; Malik A; Unni R; Arya LS; Pandey RM; Dawar R
Pediatr Blood Cancer; 2008 Feb; 50(2):280-3. PubMed ID: 17417795
[TBL] [Abstract][Full Text] [Related]
37. Expression of CD68+ tumor-associated macrophages in patients with diffuse large B-cell lymphoma and its relation to prognosis.
Hasselblom S; Hansson U; Sigurdardottir M; Nilsson-Ehle H; Ridell B; Andersson PO
Pathol Int; 2008 Aug; 58(8):529-32. PubMed ID: 18705775
[TBL] [Abstract][Full Text] [Related]
38. Expression of B-cell markers in classical hodgkin lymphoma: a tissue microarray analysis of 330 cases.
Tzankov A; Zimpfer A; Pehrs AC; Lugli A; Went P; Maurer R; Pileri S; Dirnhofer S
Mod Pathol; 2003 Nov; 16(11):1141-7. PubMed ID: 14614054
[TBL] [Abstract][Full Text] [Related]
39. Ratio of M2 macrophage expression is closely associated with poor prognosis for Angioimmunoblastic T-cell lymphoma (AITL).
Niino D; Komohara Y; Murayama T; Aoki R; Kimura Y; Hashikawa K; Kiyasu J; Takeuchi M; Suefuji N; Sugita Y; Takeya M; Ohshima K
Pathol Int; 2010 Apr; 60(4):278-83. PubMed ID: 20403029
[TBL] [Abstract][Full Text] [Related]
40. The prognostic relevance of tumor associated macrophages in advanced stage classical Hodgkin lymphoma.
Jakovic LR; Mihaljevic BS; Perunicic Jovanovic MD; Bogdanovic AD; Andjelic BM; Bumbasirevic VZ
Leuk Lymphoma; 2011 Oct; 52(10):1913-9. PubMed ID: 21663512
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]